505 related articles for article (PubMed ID: 30015962)
1. Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer.
Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
Oncol Rep; 2018 Oct; 40(4):2215-2223. PubMed ID: 30015962
[TBL] [Abstract][Full Text] [Related]
2. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
[TBL] [Abstract][Full Text] [Related]
3. Effect of modification of MTDH gene expression on colorectal cancer aggressiveness.
El-Ashmawy NE; El-Zamarany EA; Khedr EG; Abo-Saif MA
Gene; 2019 May; 698():92-99. PubMed ID: 30836117
[TBL] [Abstract][Full Text] [Related]
4. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
[TBL] [Abstract][Full Text] [Related]
5. MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment.
Gu C; Feng L; Peng H; Yang H; Feng Z; Yang Y
Oncotarget; 2016 Jan; 7(4):4559-69. PubMed ID: 26683226
[TBL] [Abstract][Full Text] [Related]
6. Effect of HOXA6 on the proliferation, apoptosis, migration and invasion of colorectal cancer cells.
Wu S; Wu F; Jiang Z
Int J Oncol; 2018 Jun; 52(6):2093-2100. PubMed ID: 29620285
[TBL] [Abstract][Full Text] [Related]
7. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of 53BP1 inhibits the radiosensitivity of colorectal cancer.
Xiao Y; Zheng X; Huang A; Liu T; Zhang T; Ma H
Int J Oncol; 2016 Oct; 49(4):1600-8. PubMed ID: 27499037
[TBL] [Abstract][Full Text] [Related]
9. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
[TBL] [Abstract][Full Text] [Related]
10. MTDH and MAP3K1 are direct targets of apoptosis-regulating miRNAs in colorectal carcinoma.
Salem SM; Hamed AR; Mosaad RM
Biomed Pharmacother; 2017 Oct; 94():767-773. PubMed ID: 28802228
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-1271 suppresses the proliferation and invasion of colorectal cancer cells by regulating metadherin/Wnt signaling.
Sun X; Zhai H; Chen X; Kong R; Zhang X
J Biochem Mol Toxicol; 2018 Feb; 32(2):. PubMed ID: 29315995
[TBL] [Abstract][Full Text] [Related]
12. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
[TBL] [Abstract][Full Text] [Related]
13. miR‑3664‑5P suppresses the proliferation and metastasis of gastric cancer by attenuating the NF‑κB signaling pathway through targeting MTDH.
Jiao Y; Yang H; Qian J; Gong Y; Liu H; Wu S; Cao L; Tang L
Int J Oncol; 2019 Mar; 54(3):845-858. PubMed ID: 30628643
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of MTDH knockdown by artificial MicroRNA interference - functions as a potential tumor suppressor in breast cancer.
Wang S; Shu JZ; Cai Y; Bao Z; Liang QM
Asian Pac J Cancer Prev; 2012; 13(6):2813-8. PubMed ID: 22938464
[TBL] [Abstract][Full Text] [Related]
15. CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitro.
Zhong G; Li H; Shan T; Zhang N
Int J Clin Exp Pathol; 2015; 8(3):2809-15. PubMed ID: 26045788
[TBL] [Abstract][Full Text] [Related]
16. miR-217 suppresses proliferation, migration, and invasion promoting apoptosis via targeting MTDH in hepatocellular carcinoma.
Zhang M; Li M; Li N; Zhang Z; Liu N; Han X; Liu Q; Liao C
Oncol Rep; 2017 Mar; 37(3):1772-1778. PubMed ID: 28184926
[TBL] [Abstract][Full Text] [Related]
17. miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer.
Guo X; Zhu Y; Hong X; Zhang M; Qiu X; Wang Z; Qi Z; Hong X
Cell Death Dis; 2017 Jul; 8(7):e2958. PubMed ID: 28749470
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
Li C; Cai S; Wang X; Jiang Z
Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
[TBL] [Abstract][Full Text] [Related]
19. Metadherin regulates actin cytoskeletal remodeling and enhances human gastric cancer metastasis via epithelial-mesenchymal transition.
Du Y; Jiang B; Song S; Pei G; Ni X; Wu J; Wang S; Wang Z; Yu J
Int J Oncol; 2017 Jul; 51(1):63-74. PubMed ID: 28534938
[TBL] [Abstract][Full Text] [Related]
20. MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH.
Chen Z; Ma Y; Pan Y; Zhu H; Yu C; Sun C
Mol Cell Probes; 2018 Aug; 40():19-26. PubMed ID: 29908229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
